Clinical trial Recruiting at 1 site Interventional Ages 60 and up

CBT-I with Melatonin for Older Adults with Chronic Insomnia

Official title: Efficacy of Cognitive Behavioural Therapy for Insomnia With Adjuvant Melatonin Treatment in Older Adults With Chronic Insomnia: A Randomised Controlled Trial

Run by The University of Hong Kong · NCT07695246 · Data updated 2026-11-12

In people aged 60 and over with chronic insomnia, researchers will test whether CBT-I plus nightly melatonin helps sleep better than CBT-I with a placebo or sleep-health education with placebo.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment183 (estimated)
SponsorThe University of Hong Kong
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Hong Kong)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedAugust 1, 2029
Study endsAugust 1, 2029
Registry record updatedAugust 21, 2026
Trial IDNCT07695246 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese adults aged 60 or older diagnosed with insomnia disorder (DSM-5) and ISI > 14, willing to participate in four weekly group sessions.

Probably not a fit

Patients whose insomnia is primarily caused by other sleep disorders or medical conditions may derive limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind study will compare three groups over four weeks: CBT-I with melatonin, CBT-I with placebo, and sleep-health psychoeducation with placebo. Participants will complete sleep diaries, questionnaires, actigraphy, and polysomnography to measure sleep, circadian rhythm, mood, fatigue, and cognitive function. Assessments occur at baseline, mid-treatment, post-treatment, and follow-ups at three and six months for the CBT-I groups. The study will recruit adults 60+ with DSM-5 insomnia disorder and ISI scores above 14, and will use 3 mg immediate-release melatonin or matched placebo taken 30 minutes before bedtime.

Why it matters

Potential benefit: If successful, the approach could offer a more effective treatment option for improving sleep and daytime functioning in older adults with insomnia.

How similar studies have gone: Previous CBT-I studies show benefit for insomnia; adding melatonin is being tested for potential added improvement in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Chinese aged ≥ 60.
2. Provision of written informed consent.
3. Having a DSM-5 diagnosis of insomnia disorder (i.e., having difficulty initiating sleep, maintaining sleep, or early morning awakening at least three times a week for at least three months, with clinically significant impairment or distress).
4. Having a score of \> 14 on the ISI, indicating clinical insomnia.

Exclusion Criteria:

1. Having a current diagnosis or a history of manic or hypomanic episodes, schizophrenia spectrum disorders, neurodevelopmental disorders, neurocognitive disorders, organic mental disorders, intellectual disabilities, or substance abuse or dependence.
2. Having a progressive medical condition directly related to the onset and course of insomnia (e.g., cancer, chronic pain).
3. Undergoing treatment for diseases known to affect sleep (e.g., chemotherapy).
4. Having an untreated sleep disorder that may disrupt sleep continuity and quality (e.g., sleep-disordered breathing) except for insomnia disorder.
5. Having mild to significant cognitive impairment, defined by having a score of \< 22 on MOCA.
6. Concurrent and regular use of extraneous melatonin or melatonin agonist (e.g., ramelteon).
7. Receiving concurrent psychological treatment for insomnia.
8. Meeting potential contraindications for melatonin (e.g., undergoing dialysis) or concurrently using medications that have a potential drug interaction with melatonin (e.g., anticoagulant and anti-platelet).
9. Being a night shift worker.

Where it's running

  • Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.